Interestingly, a higher CD97 expression (MFI ratio) in bone marrow blasts was associated with a lower percentage of CD34+ and/or CD117+ AML patients as well as presence of mutations in the FLT3 and NPM1 gene. The gene discussed is CD34; the disease is acute myeloid leukemia.